Pacira Biosciences Announces Settlement Of U.S. Patent Litigation For Exparel

Reuters
08 Apr
April 7 (Reuters) - Pacira Biosciences Inc ::
*PACIRA BIOSCIENCES ANNOUNCES SETTLEMENT OF U.S. PATENT LITIGATION FOR EXPAREL
*PACIRA BIOSCIENCES INC - FRESENIUS KABI LICENSED TO SELL GENERIC BUPIVACAINE IN U.S. FROM 2030
*PACIRA BIOSCIENCES INC - FRESENIUS TO SELL GENERIC BUPIVACAINE WITHOUT LIMITATIONS FROM 2039

((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))
Source Date/Time = 07-APR-202520:30:00.037 GMT

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10